M. S. S. Adam, P. G. Jones, J. W. Heinicke
FULL PAPER
5-Methyl-2-(phenylamino)-3-phosphanylpyridine (2c): Reduction of 43 Hz, Cq-3a), 137.97 (d, 2J = 19.0 Hz, CH-4), 146.78 (d, 2J =
1c (5.0 g, 15.6 mmol) by LiAlH4 pellets (1.8 g, 47.4 mmol) provided
1.8 g (53%) of colorless crude viscous oily 2c, which was used with-
6.6 Hz, Cq-7a), 146.81 (d, 4J = 3.0 Hz, CH-6), 161.11 (d, 1J =
54.5 Hz, Cq-2) ppm. 31P{1H} NMR (CDCl3): δ = 65.9 ppm. MS
(EI 70 eV, 285 °C): m/z (%) = 179 (10), 178 (86) [M]+, 163 (48), 150
1
out further purification for cyclocondensations. H NMR (C6D6):
1
δ = 1.82 (s, 3 H, 5-CH3), 3.24 (d, JPH = 222.0 Hz, 2 H, PH2), 6.52 (100), 149 (22), 122 (18), 92 (17), 69 (18). HRMS (ESI in MeOH,
(br. s, 1 H, NH), 6.98 (t, 3J = 7.3 Hz, 1 H, p-H), 7.24–7.32 (m, 3
NH4OAc): calcd. for C9H12N2P+ [M + H]+ 179.07329; found
179.07326.
3
H, 4-H, m-H), 7.74 (d br, J = 7.9 Hz, 2 H, o-H), 8.08 (br. s, 1 H,
6-H) ppm. 13C{1H} NMR (C6D6): δ = 17.72 (CH3-5), 108.30 (d, 1J
5-Methyl-1-phenyl-1,3-azaphospholo[5,4-b]pyridine (4c): Compound
2c (1.50 g, 6.94 mmol) and N,N-dimethylformamide dimethyl ace-
tal (0.95 mL, 7.14 mmol) gave 0.48 g (31%) 4c, which, after high
vacuum distillation at 10–5 mbar/56–60 °C (bath temperature),
3
= 15.2 Hz, Cq-3), 120.45 (2 CH-o), 122.81 (CH-p), 124.53 (d, J =
9.2 Hz, Cq-5), 129.70 (2 CH-m), 142.19 (Cq-i), 147.84 (d, 2J =
32.0 Hz, CH-4), 150.01 (CH-6), 156.40 (Cq-2) ppm. 31P{1H} NMR
(C6D6): δ = –150.6 ppm. MS (EI 70 eV, 340 °C): m/z (%) = 217
(11), 216 (100) [M]+, 215 (41), 182 (40), 138 (24), 93 (32). HRMS
(EI): calcd. for C12H13N2P+ 216.0816; found 216.0812.
1
formed white crystals, m.p. 78 °C. H NMR (CDCl3, ref. 7.25): δ
5
= 2.45 (d, JPH = 0.6 Hz, 3 H, 5-CH3), 7.43 (tt, 1 H, p-H), 7.50–
3
4
5
7.63 (m, 4 H, 2 m-H, 2 o-H), 8.23 (ddd, JPH = 3.0, J = 2.2, J =
2
3-Phosphanyl-2-[(2Ј-pyridyl)amino]pyridine (2d): Reduction of 1d
0.8 Hz, 1 H, 4-H), 8.34 (s br, 1 H, 6-H), 8.79 (d, JPH = 37.6 Hz, 1
(0.69 g, 2.25 mmol) by LiAlH4 pellets (0.26 g, 6.85 mmol) furnished H, 2-H) ppm. 13C{1H} NMR (CDCl3): δ = 18.20 (CH3-5), 125.62
0.25 g (55%) of pale yellow oily 2d, contaminated by ca. 8 mol-% of
the P–C cleavage product 2dЈ. The crude product was used without
(superimposed, Cq-5), 125.76 (2 CH-o), 127.86 (CH-p), 129.28 (2
2
CH-m), 133.72 (d, 1J = 43.2 Hz, Cq-3a), 138.07 (d, J = 19.1 Hz,
1
3
4
further purification. 2d: 1H NMR (CDCl3): δ = 3.73 (d, JPH
=
CH-4), 140.21 (d, J = 2.4 Hz, Cq-i), 147.56 (d, J = 2.8 Hz, CH-
203.3 Hz, 2 H, PH2), 6.72 (dd, J = 7.3, 4.8 Hz, 1 H, 5Ј-H), 6.83 6), 151.67 (d, 2J = 6.5 Hz, Cq-7a), 162.69 (d, 1J = 54.3 Hz, CH-
3
3
4
(ddd, J = 7.3, 5.0, J = 0.9 Hz, 1 H, 5-H), 7.50 (br. s, 1 H, NH),
2) ppm. 31P{1H} NMR (CDCl3): δ = 71.5 ppm. MS (EI 70 eV,
25 °C): m/z (%) = 227 (13), 226 (100) [M]+, 225 (61), 184 (30), 183
(64), 84 (14), 77 (18), 51 (14). HRMS (EI): calcd. for C13H11N2P+
226.0660; found 226.0656.
7.59 (td, 3J = 8.5, 3J = 7.3, 4J = 1.9 Hz, 1 H, 4Ј-H), 7.75 (ddd, 3JPH
3
4
3
4
= 10.8, J = 7.4, J = 1.9 Hz, 1 H, 4-H), 8.18 (ddd, J = 5.0, J =
1.9, 5J = 0.8 Hz, 1 H, 6-H), 8.21 (d br, superimposed, J = 4–5 Hz,
3
1 H, 6Ј-H), 8.30 (d br, 3J = 8.5 Hz, 1 H, 3Ј-H) ppm. 13C{1H} NMR
(CDCl3): δ = 109.38 (d, 1J = 16.5 Hz, Cq-3), 112.45 (CH-3Ј), 116.01
The attempt to isolate 4c before distillation by overlayering of a
saturated solution of the crude product in thf by n-hexane led to
single crystals of 6c, the dimer of the phosphaalkene precursor. The
structure of 6c is depicted in Figure 3, and the crystal data are
given in Table 1. Crude 4c also contains 20 mol-% of 5-methyl-2-
phenylaminopyridine (2dЈ) as impurity. 1H NMR (CDCl3): δ = 2.20
(s, 3 H, 5-CH3), 6.82 (br. d, 3J = 8.5 Hz, 3-H), 7.00 (m, p-CH),
7.27–7.32 (m, 4 H, o-H, m-H), 7.32 (dd, superimposed, 1 H, 4-H),
8.03 (dd, 4J = 1.5, 5J = 0.7 Hz, 1 H, 6-H) ppm. 13C{1H} NMR
(CDCl3): δ = 17.50 (CH3-5), 108.23 (CH-3), 119.56 (2 CH-o),
122.20 (CH-p), 124.08 (Cq-5), 129.21 (2 CH-m), 138.54 (CH-4),
140.93 (Cq-i), 147.91 (CH-6), 153.77 (s, Cq-2) ppm.
3
(d, J = 9.0 Hz, CH-5), 117.43 (CH-5Ј), 137.79 (CH-4Ј), 146.51 (d,
2J = 30.2 Hz, CH-4), 147.81 (CH-6Ј), 148.83 (CH-6), 153.20 (Cq-
2Ј), 155.85 (noise level, Cq-2) ppm. 31P{1H} NMR (CDCl3): δ =
–147.5 ppm. MS (EI 70 eV, 50 °C): m/z (%) = 204 (12), 203 (100)
[M]+, 202 (81), 187 (21), 171 (24) [M – PH]+, 170 (80), 123 (36),
109 (61), 78 (84). HRMS (ESI in MeOH, NH4OAc): calcd. for:
C10H11N3P+ [M + H]+ 204.06851; found 204.06862. 2dЈ: 13C NMR:
δ = 111.53 (CH-3), 116.31 (CH-5), 137.66 (CH-4), 147.69 (CH-6),
ca. 154 (Cq-2) ppm.
General Procedure for the Synthesis of 4 and 5: A mixture of N,N-
dimethylformamide or N,N-dimethylacetamide dimethyl acetal and
1a–d was heated with stirring for about 5 d at 40–50 °C. The prod-
uct mixture was separated by distillation at ca. 10–5 mbar.
1-(2Ј-Pyridyl)-1,3-azaphospholo[5,4-b]pyridine (4d): Compound 2d
(0.43 g, 2.12 mmol) and N,N-dimethylformamide dimethyl acetal
(0.32 mL, 2.41 mmol) gave oily 4d, which crystallized after distil-
5-Methyl-1H-1,3-azaphospholo[5,4-b]pyridine (4a): Compound 2a lation at 10–5 mbar/58–62 °C (bath temperature), yield 0.21 g
(0.20 g, 1.43 mmol) and N,N-dimethylformamide dimethyl acetal
(47%), m.p. 79 °C. 1H NMR (CDCl3 ref. solv. 7.25): δ = 7.23 (ddd,
(0.20 mL, 1.50 mmol) gave 0.12 g (56%) 4a, which crystallized after 3J = 7.8, JPH ≈ 4J ≈ 1.9 Hz, 1 H, 5-H), 7.33 (ddd, 3J = 7.3, 4.9, J
4
4
distillation at 10–5 mbar/48–50 °C (bath temperature). 1H NMR = 1.0 Hz, 1 H, 5Ј-H), 7.93 (ddd, 3J = 8.3, 7.3, 4J = 1.9 Hz, 1 H,
3
4
3
4
(CDCl3): δ = 2.48 (s, 3 H, 5-CH3), 8.26 (t br, JPH ≈ J = 2–3 Hz, 4Ј-H), 8.46 (ddd, 3J = 7.8, JPH = 3.2, J = 1.8 Hz, 1 H, 4-H), 8.51
2
3
4
5
3
4
1 H, 4-H), 8.36 (s br, 1 H, 6-H), 8.82 (d br, JPH = 37.8 Hz, 1 H, (dt, J = 8.3, J ≈ JPH ≈ 1 Hz, 1 H, 3Ј-H), 8.55 (dt, J = 4.6, J ≈
2-H), 11.22 (br. s, 1 H, NH) ppm. 13C{1H} NMR (CDCl3): δ = 5JPH = 1.5 Hz, 1 H, 6-H), 8.61 (ddd, J = 4.9, J = 1.9, J = 1 Hz,
3
4
5
18.26 (CH3-5), 125.29 (d, 3J = 10.4 Hz, Cq-5), 133.29 (d, 1J = 1 H, 6Ј-H), 9.62 (d br, JPH = 38.4 Hz, 1 H, CH-2) ppm. 13C{1H}
2
42.7 Hz, Cq-3a), 139.12 (d, 2J = 18.0 Hz, CH-4), 145.94 (CH-6), NMR (CDCl3): δ = 117.09 (d, 3J = 9.9 Hz, CH-5), 118.57 (CH-5Ј),
1
151.63 (d, 2J = 5.5 Hz, Cq-7a), 160.01 (d, JPC = 55.4 Hz, Cq- 122.25 (CH-3Ј), 134.77 (d, 1J = 43.1 Hz, Cq-3a), 138.19 (CH-4Ј),
2) ppm. 31P{1H} NMR (CDCl3): δ = 78.3 ppm. MS (EI 70 eV,
260 °C): m/z (%) = 150 (6) [M]+, 149 (100), 148 (7), 98 (16), 85
(15), 84 (14), 43 (29). HRMS (EI): calcd. for C7H7N2P+ 150.0347;
found 150.0349.
138.78 (d, 2J = 19.6 Hz, CH-4), 145.95 (d, 4J = 2.9 Hz, CH-6),
2
148.86 (CH-6Ј), 158.92 (low intensity d, J = 7 Hz, Cq-7a), 161.95
1
(d, J = 52.2 Hz, CH-2) ppm, Cq-2Ј at noise level. 31P{1H} NMR
(CDCl3): δ = 76.0 ppm. MS (EI 70 eV, 250 °C): m/z (%) = 213 (8)
[M]+, 186 (21), 178 (93), 177 (24), 163 (53), 150 (100), 149 (24).
HRMS (ESI in MeOH, NH4OAc): calcd. for C11H9N3P+ [M +
H]+ 214.05286; found 214.05299.
1-Ethyl-5-methyl-1,3-azaphospholo[5,4-b]pyridine (4b): Compound
2b (0.36 g, 2.14 mmol) and N,N-dimethylformamide dimethyl ace-
tal (0.30 mL, 2.26 mmol) gave 0.23 g (60%) of 4b, forming a white
powder after distillation at 10–5 mbar/40 °C (bath temperature). 1H
2,5-Dimethyl-1H-1,3-azaphospholo[5,4-b]pyridine (5a): Compound
1a (0.34 g, 2.43 mmol) and N,N-dimethylacetamide dimethyl acetal
3
NMR (CDCl3): δ = 1.51 (t, J = 7.2 Hz, 3 H, CH3), 2.45 (s, 3 H,
3
5-CH3), 4.51 (t, J = 7.2 Hz, 2 H, CH2), 8.19 (unresolvd. m, 1 H, (0.39 mL, 2.67 mmol) were heated for 1 d at 50 °C. 31P NMR spec-
2
4-H), 8.34 (br. s, 1 H, 6-H), 8.67 (d br, JPH = 37.7 Hz, 1 H, 2-
troscopic monitoring showed formation of a mixture of an interme-
H) ppm. 13C{1H} NMR (CDCl3): δ = 15.32 (CH3), 18.22 (CH3-5),
diate phosphaalkene 3a (R3 = Me) and product 5a (in CDCl3 δ =
43.67 (NCH2), 124.93 (d, 3J = 10.4 Hz, Cq-5), ca. 134.0 (d, 1J = 49.5, 66.6 ppm; intensity ca. 1:1). Heating was continued for 4 d
3312
www.eurjic.org
© 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Inorg. Chem. 2010, 3307–3316